Non-Billable / Non-Specific Code
ICD-10-CM C69.5 is the diagnosis code for Malignant neoplasm of lacrimal gland and duct. This code falls under the section "Malignant neoplasms of eye, brain and other parts of central nervous system" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where C69.5 sits in the ICD-10-CM classification helps ensure proper coding:
No, C69.5 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C69.5 is the ICD-10-CM diagnosis code for "Malignant neoplasm of lacrimal gland and duct". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C69.5 is C69 ("Malignant neoplasm of eye and adnexa"). C69.5 provides a more specific classification within this category.
C69.5 is located in Section C69-C72 — "Malignant neoplasms of eye, brain and other parts of central nervous system" within Chapter 2 of the ICD-10-CM Tabular List.
C69.5 has 3 sub-code(s) that provide more specific detail: C69.50, C69.51, C69.52.
Use C69.5 when the patients documented diagnosis matches "Malignant neoplasm of lacrimal gland and duct" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neoplasm of lacrimal gland and duct is C69.5.
No, C69.5 is non-billable. Use a more specific sub-code for primary diagnosis billing.
C69.5 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C69.5 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.